Ravi Pharmascience Private Limited

Ravi Pharmascience Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH2021PTC353761 Incorporated 19 January 2021 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2025
₹1.6 Lakh
▼ 22% YoY
Net profit · FY 2025
₹26,240
Net margin 16.4%
EBITDA · FY 2025
₹36,049
EBITDA margin 22.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Ravi Pharmascience Private Limited

Data last updated:

Ravi Pharmascience Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 January 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2021PTC353761.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinod Singhania and Siddharth Singhania.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 121 12 Floor Plot – 209 Atlanta Building Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.6 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹26,240 (net margin 16.4%) and EBITDA of ₹36,049 (EBITDA margin 22.5%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years.

Its group structure includes 1 subsidiary.

For more details, the company can be reached via its website ravidyeware.com.

Company details

CIN U24230MH2021PTC353761
Registration Number 353761
Incorporation Date 19 January 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active

Contact details

Ravi Pharmascience Private Limited's registered office is in Mumbai, Maharashtra. Its website is ravidyeware.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    121 12 Floor Plot – 209 Atlanta Building Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Ravi Pharmascience Private Limited, buy the company report.

Comprehensive company report
Ravi Pharmascience Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ravi Pharmascience is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Ravi Pharmascience Private Limited, buy the company report.

Financials of Ravi Pharmascience Private Limited

FY 2025 filings available

Ravi Pharmascience Private Limited reported revenue of ₹1.6 Lakh (down 22% YoY) for FY 2025.

Revenue · FY 2025
₹1.6 Lakh ▼ 22%
Net profit · FY 2025
₹26,240 margin 16.4%
EBITDA · FY 2025
₹36,049 margin 22.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 18%
EBITDA CAGR growth
1 year
▼ 75%
3 years · compounded
▲ 26%

Revenue has declined at a compounded annual rate (CAGR) of 18% over three years, including a 22% fall in the latest year. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹36,049
Profit Before Tax
Tax Expense
Net Profit (PAT)₹26,240
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin22.5%
Net Profit Margin16.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ravi Pharmascience Private Limited, buy the company report.

Board of directors of Ravi Pharmascience Private Limited

Ravi Pharmascience has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Vinod SinghaniaDirector19 Jan 20215 Years 9 MonthsCurrent
Siddharth SinghaniaDirector19 Jan 20215 Years 9 MonthsCurrent

Auditor

Ravi Pharmascience Private Limited is audited by M.A. Parikh & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M.A. Parikh & Co.FY 2023107556W

Shareholding

The shareholding of Ravi Pharmascience Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ravi Pharmascience Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ravi Pharmascience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Ravi Pharmascience has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Ravi Biolife Private LimitedU24299MH2020PTC352827

To see the full group structure of Ravi Pharmascience Private Limited, buy the company report.

Employees & EPFO

Ravi Pharmascience Private Limited has 1 active EPFO establishment as of Nov 12, 2026.

Active EPFO establishments
1

GST

No GST registration is on our record for Ravi Pharmascience Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Ravi Pharmascience Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Siddharth Singhania was appointed as Director on 19 Jan 2021.

AGM
Ravi Pharmascience Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Ravi Pharmascience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Siddharth Singhania was appointed as Director.
Appointed
Vinod Singhania was appointed as Director.
Incorporation
19 Jan 2021
Ravi Pharmascience Private Limited was registered on 19 Jan 2021 with Roc Mumbai I & aged 5 years 9 months as per MCA records.

Frequently asked questions

Ravi Pharmascience is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 January 2021 (5+ years old) and is registered under CIN U24230MH2021PTC353761.

Ravi Pharmascience has 2 current directors:

The latest financial statements of Ravi Pharmascience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Ravi Pharmascience is U24230MH2021PTC353761. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ravi Pharmascience was incorporated on 19 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

Siddharth Singhania was appointed as Director on 19 Jan 2021. Vinod Singhania was appointed as Director on 19 Jan 2021.

Ravi Pharmascience can be reached through the website ravidyeware.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Ravi Pharmascience is at 121 12 Floor Plot – 209 Atlanta Building Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021.

Ravi Pharmascience operates in the pharma industry, in the drug formulation and development segment.

Ravi Pharmascience has 1 subsidiary company including Ravi Biolife Private Limited.